Tuberculosis following solid organ transplantation

Area of Science:

• Transplant medicine
• Infectious diseases
• Immunology

Background:

• Organ transplantation significantly elevates patient risk for tuberculosis (TB).
• TB presents diagnostic and treatment challenges in transplant recipients due to atypical presentations, high morbidity, and mortality.
• Physicians face difficulties managing TB in immunocompromised transplant patients.

Purpose of the Study:

• To determine the incidence of tuberculosis (TB) in solid organ transplant recipients.
• To identify risk factors associated with the development of TB post-transplantation.
• To compare TB incidence in transplant patients with the general population.

Main Methods:

• A retrospective analysis of solid organ transplant recipients at a New York university medical center from 1988 to 2007.
• Identification of patients who developed TB post-transplantation.
• A nested case-control study comparing TB cases with control patients who did not develop TB, analyzing demographic and transplant-related factors.

Main Results:

• Thirteen cases of TB were identified among 4925 transplants, yielding a cumulative incidence of 264/100,000.
• Kidney transplant recipients (10 cases) and non-Caucasians showed a statistically significant increased risk for TB.
• The median time to TB diagnosis post-transplant was 11.2 months.

Conclusions:

• The incidence of TB in post-transplant patients is substantially higher than the general US background rate.
• Kidney transplant recipients and non-Caucasian individuals are identified as high-risk groups for developing TB.
• Prior exposure to TB may contribute to the increased risk in these specific patient populations.